immuneering.com

Immuneering Corporation | Maximizing the Success of New Medicines | We are here for one reason – to apply our expertise, passion, and creativity to improve the lives of people with serious diseases.

Capabilities & Solutions. Expertise & Impact. A new drug discovery platform. Identifying one target to treat a complex disease is a tall order, yet traditional drug discovery methods do not scale to multiple targets. Our platform pinpoints both single and multi-targeted drugs at unprecedented speeds. The platform is driven by AI and high-throughput data, and informed by our ongoing 10-years of experience with leading biopharma companies. Visit the careers page to see our latest opportunities!

http://www.immuneering.com/

OVERVIEW OF immuneering.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IMMUNEERING.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

May

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 14 reviews

5 star

9

4 star

2

3 star

2

2 star

0

1 star

1

Hey there! Start your review of immuneering.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.7 seconds

FAVICON PREVIEW

16x16

CONTACTS AT IMMUNEERING.COM

Zeskind PhD, Benjamin J

P.O. ●●●●●26057

Cam●●●dge , MA, 02142-0019

US

1.61●●●●8080

be●●●●●●●●●●●●●●●●@immuneering.com

View this contact

Immuneering Corporation

Zeskind PhD, Benjamin J

P.O. ●●●●●26057

Cam●●●dge , MA, 02142-0019

US

1.61●●●●8080

be●●●●●●●●●●●●●●●●@immuneering.com

View this contact

Immuneering Corporation

Zeskind PhD, Benjamin J

P.O. ●●●●●26057

Cam●●●dge , MA, 02142-0019

US

1.61●●●●8080

be●●●●●●●●●●●●●●●●@immuneering.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2008 February 07
UPDATED: 2013 December 19
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

16

YEARS
3

MONTHS
25

DAYS

NAME SERVERS

1: ns100.worldnic.com
2: ns99.worldnic.com

REGISTRAR

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

PAGES IN
THIS WEBSITE

4

SSL

EXTERNAL LINKS

4

SITE IP

97.74.181.128

LOAD TIME

1.714 sec

SCORE

6.2

PAGE TITLE

Immuneering Corporation | Maximizing the Success of New Medicines | We are here for one reason – to apply our expertise, passion, and creativity to improve the lives of people with serious diseases. | immuneering.com Reviews

<META> DESCRIPTION

Capabilities & Solutions. Expertise & Impact. A new drug discovery platform. Identifying one target to treat a complex disease is a tall order, yet traditional drug discovery methods do not scale to multiple targets. Our platform pinpoints both single and multi-targeted drugs at unprecedented speeds. The platform is driven by AI and high-throughput data, and informed by our ongoing 10-years of experience with leading biopharma companies. Visit the careers page to see our latest opportunities!

<META> KEYWORDS

1 news

2 immuneering is hiring

3 immuneering publications

4 overview

5 board and sab

6 leadership team

7 careers

8 2015 immuneering corporation

9 publications

10 immuneering

CONTENT

Page content here

KEYWORDS ON PAGE

news,immuneering is hiring,immuneering publications,overview,board and sab,leadership team,careers,2015 immuneering corporation,publications,immuneering,connect on linkedin,site design

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Immuneering Corporation | Maximizing the Success of New Medicines | We are here for one reason – to apply our expertise, passion, and creativity to improve the lives of people with serious diseases. | immuneering.com Reviews

https://immuneering.com

Capabilities & Solutions. Expertise & Impact. A new drug discovery platform. Identifying one target to treat a complex disease is a tall order, yet traditional drug discovery methods do not scale to multiple targets. Our platform pinpoints both single and multi-targeted drugs at unprecedented speeds. The platform is driven by AI and high-throughput data, and informed by our ongoing 10-years of experience with leading biopharma companies. Visit the careers page to see our latest opportunities!

INTERNAL PAGES

immuneering.com

1

Teva and Immuneering Co-author Publication Demonstrating that Key Genes Respond Differently to COPAXONE® (glatiramer acetate injection) Versus a Purported Generic Glatiramer Acetate | Immuneering Corporation | Maximizing the Success of New Medicines

http://immuneering.com/2014/01/13/teva-and-immuneering-co-author-publication-demonstrating-that-key-genes-respond-differently-to-copaxone-glatiramer-acetate-injection-versus-a-purported-generic-glatiramer-acetate

Capabilities & Solutions. Expertise & Impact. Teva and Immuneering Co-author Publication Demonstrating that Key Genes Respond Differently to COPAXONE (glatiramer acetate injection) Versus a Purported Generic Glatiramer Acetate. Http:/ www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0083757. Teva’s press release on the paper is reproduced below, and is also available online at:. Http:/ www.tevapharm.com/Media/News/Pages/2014/1890100.aspx. JERUSALEM–(BUSINESS WIRE)–Jan. 13, 2014...The study als...

2

News | Immuneering Corporation | Maximizing the Success of New Medicines

http://immuneering.com/news

Capabilities & Solutions. Expertise & Impact. Immuneering announces publication of Alzheimer’s Disease study in Scientific Reports. Teva and Immuneering Announce Teva’s Purchase of 51% Equity Share of Genomic-Analysis Company. We are excited to work together with our colleagues at Teva to improve the lives of patients suffering from CNS diseases. Immuneering Corporation Expands Alliance with Bristol-Myers Squibb. CAMBRIDGE, Mass., Jan. 29, 2014 /PRNewswire/ Immuneering Corporation announced today...Teva ...

3

Teva and Immuneering Announce Teva’s Purchase of 51% Equity Share of Genomic-Analysis Company | Immuneering Corporation | Maximizing the Success of New Medicines

http://immuneering.com/2015/08/03/teva-and-immuneering-announce-tevas-purchase-of-51-equity-share-of-genomic-analysis-company

Capabilities & Solutions. Expertise & Impact. Teva and Immuneering Announce Teva’s Purchase of 51% Equity Share of Genomic-Analysis Company. We are excited to work together with our colleagues at Teva to improve the lives of patients suffering from CNS diseases. READ FULL PRESS RELEASE. Capabilities & Solutions. Expertise & Impact.

4

Immuneering Corporation Expands Alliance with Bristol-Myers Squibb | Immuneering Corporation | Maximizing the Success of New Medicines

http://immuneering.com/2014/01/29/immuneering-corporation-expands-alliance-with-bristol-myers-squibb

Capabilities & Solutions. Expertise & Impact. Immuneering Corporation Expands Alliance with Bristol-Myers Squibb. Immuneering Corporation Expands Alliance with Bristol-Myers Squibb. Immuneering’s team of MIT-trained PhDs will perform advanced analyses on data from Bristol-Myers Squibb to derive new biological insights. Immuneering uses internally developed proprietary algorithms in combination with software licensed from leading research institutions. Immuneering’s proprietary algorithms extend beyond tr...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

teva.co.il

טבע רכשה 51% ממניות Immuneering - חברה לניתוח הגנום - חדשות אחרונות - טבע בישראל

http://www.teva.co.il/Media/NewsRoom/Pages/Teva-Immuneering-PR.aspx

הרשת למצוינות בחקר מדעי המוח. מרכז המחקר והפיתוח הגנרי. המפעל הסטרילי בכפר סבא. מפעל הטבליות בכפר סבא. צור קשר מחלקת אחריות חברתית. פרס על שם מייסדי טבע. עולם הזדמנויות של צמיחה. לגלות, להשתלב, לצמוח. טבע רכשה 51% ממניות Immuneering - חברה לניתוח הגנום. טבע תציג נתונים חדשים ממחקרים בתחום מערכת הנשימה. טבע תארח סקירה אודות עסק התרופות הגנריות ב- 9 בספטמבר, 2016. טבע מאשרת את קבלת החלטת משרד הפטנטים האמריקאי בנוגע לשני פטנטים של קופקסון 40 מג. טבע מודיעה על השקת הגרסה הגנרית של טבליות Gleevec בארהב. טבע ה...

janetleydon.com

Immuneering — Janet Leydon

http://www.janetleydon.com/immuneering

Designer and Creative Services Consultant. Immuneering is the trusted advisor the the world's leading pharmaceutical companies for genetic, genomic and proteomic data analysis with high-value results to improve patients' lives. To uncover a unqiue and compelling brand position to be used as the guide in developing the companies brand on all platforms. A discovery process initiated this work. Work Completed at D&CO. Opyright Janet Leydon Design 2016.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

4

SOCIAL ENGAGEMENT

immuneering

OTHER SITES

immuneenhancer.com

Price Request - BuyDomains

Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.

immuneenhancers.com

immuneenhancing.com

Click here to proceed.

immuneenhancing.net

Click here to proceed.

immuneer.com

Immuneering Corporation

immuneering.com

Immuneering Corporation | Maximizing the Success of New Medicines | We are here for one reason – to apply our expertise, passion, and creativity to improve the lives of people with serious diseases.

Capabilities & Solutions. Expertise & Impact. A new drug discovery platform. Identifying one target to treat a complex disease is a tall order, yet traditional drug discovery methods do not scale to multiple targets. Our platform pinpoints both single and multi-targeted drugs at unprecedented speeds. The platform is driven by AI and high-throughput data, and informed by our ongoing 10-years of experience with leading biopharma companies. Visit the careers page to see our latest opportunities!

immuneering.net

Immuneering Corporation

immuneering.org

Immuneering Corporation

immuneers.com

Immuneering Corporation

immunefactor.com

immunefactor.net

Welcome immunefactor.net - BlueHost.com

Web Hosting - courtesy of www.bluehost.com.